promed pharmacy semaglutide Ozempic® (semaglutide) — FDA-approved type

it stimulates insulin secretion only when blood glucose levels are elevated

PIONEER 2 and 10 were open-label studies, deemed high risk for performance bias, while the others employed a double-blind design

Increased muscle loss A 2024 meta-analysis of GLP-1 medications found that ~25% of total weight loss results from lean mass rather than fat, likely due to insufficient protein intake and resistance training among participants in these studies 1

The term refers to changes in ones facial appearance due to rapid weight loss

After 72 weeks of treatment, patients treated with semaglutide showed significant reductions in fatty accumulation in the liver as well as liver scarring

Chronic stress elevates cortisol and ghrelin, opposing GLP-1's appetite-suppressing effects